1. Technology overview
Vinaver Medical is a Serbian medical technology startup based in Novi Sad, founded to bring artificial intelligence to spectral computed tomography (CT) imaging. Emerging from Serbia’s Science and Technology Park network and backed by a pre-seed round from the Digital Serbia Initiative angel network in 2025, the company addresses the gap between what spectral CT scanners can capture and the tissue-level detail clinicians actually receive in standard reports.
Its flagship product, TissueXplorer SPR, is vendor-agnostic software that converts spectral CT images from scanners already installed in a hospital into high-resolution stopping-power maps used for proton and particle radiotherapy planning. Two further modules, TissueXplorer GEM for contrast visualization and TissueXplorer ZeRo for tissue density and composition mapping, are in development. Customers are radiotherapy and proton therapy centers, radiologists, cardiologists and medical physicists who need more precise tissue characterization without replacing existing CT hardware.
2. Highlighted features & specifications
1. Vendor-agnostic processing: Works with spectral CT data from existing scanners regardless of manufacturer, avoiding new hardware purchases.
2. Stopping-power mapping: Converts spectral CT scans into high-resolution stopping-power maps for proton and particle therapy planning.
3. Tissue characterization: Improves material and tissue differentiation in cardiac and abdominal diagnostic imaging.
4. Contrast enhancement module: TissueXplorer GEM (in development) visualizes gadolinium enhancement for clearer contrast reading.
5. Density mapping module: TissueXplorer ZeRo (in development) maps tissue density and composition for broader diagnostic use.
6. Clinical integration: Designed to plug into radiotherapy and radiology workflows already in place at hospitals.
One platform connecting startups, corporations, research institutions, regions and investors
Southeast Asia Innovation Landscape 2026








































